Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
CRANBURY, N.J., June 23, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) announced today that Alan W. Dunton, M.D., formally joined Palatin’s Board of Directors on June 22, 2011 as an independent director and member of Palatin’s Audit and Compensation Committees. “Dr. Dunton brings Palatin both substantial drug development experience and clinical research experience,” …
Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc. Read More »